1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => FreeToRead
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
RT Journal Article
SR Electronic
T1 CT for Headache: Cost/Benefit for Subarachnoid Hemorrhage
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 567
OP 572
VO 1
IS 6
A1 Knaus, William A.
A1 Wagner, Douglas P.
A1 Davis, David O.
YR 1980
UL http://www.ajnr.org/content/1/6/567.abstract
AB Nationwide cost and benefit was estimated for performing computed tomography (CT) on headache patients in the hope of discovering a specific finding, subarachnoid hemorrhage. Case finding costs were estimated using a previously published survey of CT use at a university hospital where, of 258 headache patients scanned, two had subarachnoid bleeding due to ruptured aneurysms. The incidence and natural history of ruptured aneurysms from a large-scale clinical trial and the outcome of surgery from the recent literature were used in the calculations. The results ranged from a worst case calculation of $24,713/year and $543,688/person saved (ignoring all other diagnoses) to a best case calculation of $1,999/year and $43,975/person assuming that other positive diagnoses were of equal outcome to ruptured aneurysms. The analysis, using a technique recommended as a model for future determinations of this type, also demonstrated that a most important variable in determining costs is the case finding rate. If there is a need to improve the use of new diagnostic technologies, such as CT, concentration should be on the identification of the characteristics of high-yield patient groups.